-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-03-20
FFBUSX:NMF-FFBUSX (USD)
MUTUAL FUND | Others |
Last Closing
USD 9.8008Change
0.00 (-0.04)%Market Cap
N/AVolume
N/AAnalyst Target
N/A
N/A
Verdict
Values as of: 2025-03-20
MUTUAL FUND | Others |
Last Closing
USD 9.8008Change
0.00 (-0.04)%Market Cap
N/AVolume
N/AAnalyst Target
N/AN/A
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
VRGWX | Vanguard Russell 1000 Growth I.. |
-1.56 (-0.21%) |
USD 26.28B |
XMDYX | Mid Cap SPDR 400 Trust Series .. |
-4.00 (-0.73%) |
USD 19.32B |
VRTIX | Vanguard Russell 2000 Index Fu.. |
-2.06 (-0.64%) |
USD 10.02B |
VRVIX | Vanguard Russell 1000 Value In.. |
-0.78 (-0.24%) |
USD 9.85B |
VRNIX | Vanguard Scottsdale Funds - Va.. |
-1.13 (-0.23%) |
USD 7.05B |
VRTTX | Vanguard Russell 3000 Index Fu.. |
-1.19 (-0.25%) |
USD 3.51B |
XAODX | Alpine Total Dynamic Dividend .. |
-0.04 (-0.42%) |
USD 2.09B |
XNUVX | Nuveen Municipal Value Fd Inc |
+0.02 (+0.22%) |
USD 2.06B |
VRTGX | Vanguard Russell 2000 Growth I.. |
-2.86 (-0.77%) |
USD 1.19B |
XJPCX | Nuveen Preferred Income Opport.. |
+0.01 (+0.13%) |
USD 0.99B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
JHCS | 4.01 % | 0.40 % |
N/A |
N/A | |
BDEQ:CA | 3.11 % | 0.00 % |
N/A |
N/A | |
PRID | 2.42 % | 0.65 % |
N/A |
N/A | |
PXLG | Invesco S&P 500 GARP ETF | 2.41 % | 0.39 % |
-0.48 (0%) |
N/A |
DWPP | 2.24 % | 0.60 % |
N/A |
N/A | |
WWOW | 2.20 % | 0.00 % |
N/A |
N/A | |
LOWC | 1.24 % | 0.20 % |
N/A |
N/A | |
CMUE:CA | 1.16 % | 0.00 % |
N/A |
N/A | |
CMUE-F:CA | 1.16 % | 0.00 % |
N/A |
N/A | |
EVGBC | 1.15 % | 0.00 % |
N/A |
N/A | |
JUMF:XETRA | 0.50 % | 0.00 % |
N/A |
N/A | |
JUMF:F | 0.50 % | 0.00 % |
N/A |
N/A |
Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 12 Months | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Trailing 5 Years | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | N/A | N/A | N/A | N/A | N/A | ||
Risk Adjusted Return | N/A | N/A | N/A | N/A | N/A | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
There is nothing we particularly dislike